摘要
目的:探讨格列美脲对细颗粒物空气动力学直径<2.5μm(PM 2.5)诱导的心肌样细胞损伤的保护作用及机制研究。方法:采用噻唑蓝(MTT)确定PM2.5的干预浓度;将大鼠心肌样细胞H9c2分为对照组(含血清1640培养基)、PM2.5组(800mg·L^-1)、格列美脲低、中、高剂量组(10,20,40μmol·L^-1的格列美脲+800 mg·L^-1的PM 2.5)。培养24 h后检测H9c2细胞中肿瘤坏死因子-α(TNF-α)和白细胞介素^-1β(IL^-1β)含量,同时检测细胞中活性氧(ROS)和细胞凋亡率,检测B淋巴细胞瘤-2(Bcl-2)、Bcl-2-Associated X的蛋白质(Bax)和半胱氨酸天冬氨酸特异性蛋白酶-3(caspase-3)mRNA表达水平。结果:随着PM 2.5浓度的增加,H9c2细胞增值率降低,在800 mg·L^-1时H9c2细胞增值率降到46.28%,故选800 mg·L^-1作为PM 2.5的干预浓度;与PM 2.5组比较,格列美脲各剂量组细胞中TNF-α、IL^-1β含量、ROS荧光强度、细胞凋亡率、Bax和caspase-3 mRNA的相对表达量显著降低(P<0.05),Bcl-2 mRNA的相对表达量显著升高(P<0.05),且呈剂量相关性(P<0.05)。结论:格列美脲对细颗粒物PM2.5诱导的心肌样细胞损伤具有保护作用,其机制可能与格列美脲减轻炎症反应和氧化应激、抑制心肌细胞凋亡有关。
Objective:To investigate the protective effect and underlying mechanism of glimepiride on myocardial-like cell injury induced by PM2.5.Methods:The intervention concentration of PM2.5 was determined by MTT.Rat’s cardiomyocyte-like cells H9c2 were divided into the control group(containing serum 1640 medium),PM2.5 group(800 mg·L^-1),glimepiride low,medium and high dose groups(10,20 and 40μmol·L^-1 glimepiride+800 mg·L^-1 PM2.5).After 24 hours,the contents of TNF-αand IL^-1βin H9c2 cells were detected.The level of ROS and the apoptotic rate were detected.The mRNA expressions of Bcl-2,Bax and caspase-3 were detected as well.Results:With the increase of PM2.5 concentration,the proliferation rate of H9c2 cells decreased.At 800 mg·L^-1,the proliferation rate of H9c2 cells decreased by 46.28%.Therefore,800 mg·L^-1 was chosen as the intervention concentration of PM2.5.Compared with those in PM2.5 group,the levels of TNF-αand IL^-1β,ROS fluorescence intensity,apoptotic rate,mRNA expressions of Bax and caspase-3 in glimepiride low,medium and high dose groups decreased significantly(P<0.05),while the mRNA expression of Bcl-2 increased significantly(P<0.05),and showed a dose-dependent manner(P<0.05).Conclusion:Glimepiride has protective effect on PM2.5-induced cardiomyocyte injury.The protective effect of glimepiride on PM2.5-induced cardiomyocyte injury may be related to the alleviation of inflammatory response and oxidative stress and the inhibition of cardiomyocyte apoptosis of glimepiride.
作者
钟灵
熊秋璨
付静
王霞
赵茂宇
Zhong Ling;Xiong Qiucan;Fu Jing;Wang Xia;Zhao Maoyu(Department of Cardiovascular Medicine,Xinqiao Hospital Affiliated to Military Medical University,Chongqing 400037,China)
出处
《中国药师》
CAS
2019年第12期2279-2281,2285,共4页
China Pharmacist